E N D
1. An Evidence-Based Approach for Preventing Heart Disease
Brian V. Reamy, M.D., Col, USAF, MC
Professor & Chair – Dept. of Family Medicine
Uniformed Services University
2. Understand advances in how to assess a patient’s risk for cardiovascular disease
Plan a treatment strategy to reduce risk
Understand recent advances in prevention
Objectives
3. Introduction 2,447,910 deaths in U.S. in 2005
861,826 deaths from Cardiovascular disease
1 of every 2.8 deaths in U.S. is from CV disease
AHA Heart disease & Stroke Statistics – 2008 Update. Circulation 117:e25-e146.
4. Traditional risk factors can predict who will have CV events in 90% of all cases.
HTN, Smoking, FHx, Hyperlipidemia
Introduction – Prevention of CVD
5. Background: best summary of the origins & progression of atherosclerosis: McGill et al. Preventing Heart Disease in the 21st Century: Implications of the pathobiologic determinants of atherosclerosis in youth (PDAY) study. Circulation 2008:117:1216-1227.
Convergence of data from several trials over the past 4 decades has shown that ASCVD starts as early as age 2 years and progresses at a predictable rate based on your individual risk factors. Prevention - Introduction
6. Models show that optimizing risk factors in adolescents and maintaining optimum risk status thru age 50 years could prevent 90% of ASCVD.
Prevention - Introduction
7. Primary Prevention: treatment of patients with lifestyle changes or medications before they have manifest cardiovascular disease.
CVD Prevention
8. Secondary Prevention: treatment of patients with lifestyle changes or medications after they have developed clinical CVD. CVD Prevention
9. Older age & male gender
Smoking
Elevated BP
Dyslipidemia
Fhx of CVD in father < 55 or mother <65 yrs.
Diabetes
BMI > 25 OR increased waist circumference
Activity level (sedentary>>>vigorous activity)
Hs-CRP level and other novel serum biomarkers…. Risk Factors
10. Patient’s who have manifest CVD are high risk
Calculation of risk for all others uses risk calculators
These calculators include a variety of CV risks
Framingham: limitation is the lack of additive risk for age > 80 yrs or Family history
http://hp2010.nhlbihin.net/atpiii/calculator.asp
Reynolds Risk Score: limitations:it is used only for patients > age 45 and requires an hs-CRP level
http://www.reynoldsriskscore.org/
New calculators likely coming with ATP IV Risk Calculation
11. Risk
Rarely miscalculate risk for patients at VERY-HIGH or LOW risk. Miscalculation of risk is an issue for those at intermediate risk.
The hope is that enhanced incorporation of genetic risk (Fhx) & novel serum biomarkers can help to properly classify these intermediate risk patients as needing or not needing intervention.
12. Current best sources:
Primary Prevention: AHA Guidelines for Primary Prevention of Cardiovascular disease and stroke. Circulation 2002;106:388-391
Secondary Prevention: AHA/ACC Guidelines for Secondary Preventin for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation; 2006:113:2363-2372. Evidence Based Guidelines
13. Both 1° & 2°Prevention in women: AHA Guidelines for cardiovascular disease prevention in Women Circulation; 2007;115:1481-1501
Explicit levels of evidence noted in recent guidelines following the Level I,II,III and A,B,C methodology. Evidence-Based Guidelines
14. 1) BP
2) Lipids
3) Diet
ETOH?
Supplements?
4) Smoking
5) Activity
6) Weight
7) Aspirin use Develop a 7 point Prevention RX for ASCVD with each Patient
15. Evidence-Based Guidelines: BPDiet, weight reduction, salt reduction, increase fruits & veggies, exercise, moderate etoh, medications
16. Evidence-Based Guidelines:LipidsStart w/TLC then follow with meds in 3 – 6 mths if not at goal LDL level. Then address HDL and TG level
17. Increase fruits and veggies
Limit ETOH to <2 drinks/day men; < 1/day in women
Reduce saturated fat & trans-fats
Women: oily fish 2 days per week
Choose whole grain high fiber foods.
Evidence-Based Guidelines: Dietary Intake
18. Walker & Reamy: Diets for Cardiovascular disease prevention. Am Fam Phy April 1, 2009
“The Mediterranean diet confers morbidity and mortality benefits in patients with known cardiovascular disease” Level A
Basic components:
Locally grown & minimally processed foods
Plant based foods(legumes, nuts, cereals, fruits, veg)
Fish & poultry w/ infrequent red meat intake
Up to 4 whole eggs per week & moderate dairy intake
Olive oil as principal source of fat
Moderate amount of red wine with meals
Eat from a colorful plate
Desserts primarily of fresh fruits
Evidence-Based Dietary Guidelines
19. Ask at every visit
Advise to quit every visit
Assess readiness
Assist in developing a plan to quit
Arrange the quit plan
Avoid exposure to environmental smoke at work and home
Evidence Based Guidelines: Smoking – 6 “A’s”
20. 30 minutes of moderate intensity physical activity on most and preferably all days of the week.
Moderate intensity = brisk walk or 40-60% MHR Evidence-Based Guidelines: physical activity
21. Maintain BMI 18.5 to 24.9kg/m2
Maintain waist circumference < 40” men
< 35” women
(measured at iliac crest horizontally) Evidence based guidelines: Weight
22. Evidence-Based Guidelines: Aspirindoses of 75-162 mg/day are as effective as higher doses
23. Omega-3 fatty acids (850-1000mg EPA & DHA) per day as a supplement in women with CHD (Level IIB)
Screen women with CHD for depression (IIB)
AVOID Hormone replacement therapy and SERM’s for 1° or 2°prevention of CVD (IIIA)
Avoid antioxidant vitamin supplements (E,C, beta-carotene) & folic acid for primary or secondary prevention of CVD (IIIA) Evidence based guidelines: unique issues for women
24. 1) BP
2) Lipids
3) Diet
ETOH?
Supplements?
4) Smoking
5) Activity
6) Weight
7) Aspirin use Develop a 7 point Prevention RX for ASCVD with each Patient
25. Cases or questions?